UOC
UBS O'Connor Portfolio holdings
AUM
$1.93B
This Quarter Return
+3.8%
1 Year Return
+38.75%
3 Year Return
+182.42%
5 Year Return
+480.25%
10 Year Return
+1,573.29%
AUM
$3.77B
AUM Growth
+$3.77B
(-6%)
Cap. Flow
-$165M
Cap. Flow
% of AUM
-4.38%
Top 10 Holdings %
Top 10 Hldgs %
58.56%
Holding
566
New
99
Increased
122
Reduced
58
Closed
164
Top Buys
Top Sells
| 1 |
CTLT
CATALENT, INC.
CTLT
|
$234M |
| 2 |
MRO
Marathon Oil Corporation
MRO
|
$222M |
| 3 |
SRCL
Stericycle Inc
SRCL
|
$172M |
| 4 |
AXNX
Axonics, Inc. Common Stock
AXNX
|
$150M |
| 5 |
PRFT
Perficient Inc
PRFT
|
$79.6M |
Sector Composition
| 1 | Technology | 30.66% |
| 2 | Energy | 16.79% |
| 3 | Financials | 8.26% |
| 4 | Consumer Staples | 8.25% |
| 5 | Materials | 8.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
SharkNinja
SN
$16.7B
| $1.95M | 0.05% |
+20,000
| New | +$1.95M |
|
152
Innoviz Technologies
INVZ
$305M
| $1.93M | 0.05% |
+1,150,000
| New | +$1.93M |
|
153
IDEAYA Biosciences
IDYA
$2.26B
| $1.87M | 0.05% |
72,716
+24,112
| +50% | +$620K |
|
154
Insmed
INSM
$30.3B
| $1.84M | 0.05% |
26,615
+4,796
| +22% | +$331K |
|
155
CommScope
COMM
$3.57B
| $1.82M | 0.05% |
+350,000
| New | +$1.82M |
|
156
Alphatec Holdings
ATEC
$2.35B
| $1.82M | 0.05% |
197,992
+35,695
| +22% | +$328K |
|
|
AACT
157
Ares Acquisition Corporation II
AACT
$706M
| $1.82M | 0.05% |
165,422
| – | – |
|
158
TJX Companies
TJX
$155B
| $1.81M | 0.05% |
+15,000
| New | +$1.81M |
|
159
BioMarin Pharmaceuticals
BMRN
$11.3B
| $1.76M | 0.05% |
+26,840
| New | +$1.76M |
|
|
BPMC
160
DELISTED
Blueprint Medicines
BPMC
| $1.76M | 0.05% |
20,133
-2,120
| -10% | -$185K |
|
161
ON Semiconductor
ON
$19.5B
| $1.73M | 0.05% |
27,500
+17,500
| +175% | +$1.1M |
|
162
iRhythm Technologies
IRTC
$5.67B
| $1.73M | 0.05% |
19,191
-5,535
| -22% | -$499K |
|
163
Orthofix Medical
OFIX
$583M
| $1.7M | 0.05% |
97,461
+12,578
| +15% | +$220K |
|
164
Analog Devices
ADI
$120B
| $1.7M | 0.04% |
8,000
+3,000
| +60% | +$637K |
|
165
Evolv Technologies
EVLV
$1.37B
| $1.7M | 0.04% |
430,223
| – | – |
|
|
ITCI
166
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $1.69M | 0.04% |
20,284
+2,941
| +17% | +$246K |
|
167
BridgeBio Pharma
BBIO
$9.91B
| $1.68M | 0.04% |
61,118
+2,522
| +4% | +$69.2K |
|
168
Cardlytics
CDLX
$47.4M
| $1.67M | 0.04% |
450,000
| – | – |
|
169
Vale
VALE
$43.6B
| $1.66M | 0.04% |
+187,296
| New | +$1.66M |
|
170
Annexon
ANNX
$225M
| $1.64M | 0.04% |
318,884
-1,690
| -0.5% | -$8.67K |
|
171
Aligos Therapeutics
ALGS
$75.1M
| $1.6M | 0.04% |
40,096
-27,000
| -40% | -$1.08M |
|
172
ADT
ADT
$7.11B
| $1.59M | 0.04% |
229,607
| – | – |
|
173
InflaRx
IFRX
$117M
| $1.55M | 0.04% |
625,589
-172,287
| -22% | -$426K |
|
174
Credicorp
BAP
$20.8B
| $1.52M | 0.04% |
8,311
| – | – |
|
175
OrthoPediatrics
KIDS
$524M
| $1.51M | 0.04% |
65,292
+13,270
| +26% | +$308K |
|